Novo Nordisk sets new record as market value soars to USD 370bn
A substantial guidance upgrade from Novo Nordisk on Thursday leads the Danish drugmaker to setting another stock record.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.